A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Phase of Trial: Phase III
Latest Information Update: 08 Sep 2017
At a glance
- Drugs Olanzapine/samidorphan (Primary) ; Olanzapine
- Indications Schizophrenia
- Focus Registrational; Therapeutic Use
- Acronyms ENLIGHTEN-2
- Sponsors Alkermes plc
- 05 Sep 2017 According to an Alkermes plc media release, data will be presented at the upcoming 30th Annual Psych Congress.
- 01 Sep 2017 Planned End Date changed from 1 Mar 2018 to 1 Sep 2018.
- 01 Sep 2017 Planned primary completion date changed from 1 Feb 2018 to 1 Aug 2018.